The Impacts of Albuminuria and Low eGFR on the Risk of Cardiovascular Death, All-Cause Mortality, and Renal Events in Diabetic Patients: Meta-Analysis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Toyama, Tadashi ^a   Furuichi, Kengo ^a   Ninomiya, Toshiharu ^b   Shimizu, Miho ^a   Hara, Akinori ^a   Iwata, Yasunori ^a   Kaneko, Shuichi ^c   Wada, Takashi ^a,c  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; ARTICLE; CARDIOVASCULAR DEATH; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; DEATH; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; MACROALBUMINURIA; MICROALBUMINURIA; RACE DIFFERENCE; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; RISK;

EID: 84883395337     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071810     Document Type: Article

References (59)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378: 31-40.
2. Yang SH, Dou KF, Song WJ (2010) Prevalence of diabetes among men and women in China. The New England journal of medicine 362: 2425-6; author reply 2426.
3. Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, et al. (2012) Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 55: 88-93.
4. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, et al. (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney international 63: 225-232.
5. Wada T, Shimizu M, Toyama T, Hara A, Kaneko S, et al. (2012) Clinical impact of albuminuria in diabetic nephropathy. Clinical and experimental nephrology 16: 96-101.
6. Vlek ALM, Van der Graaf Y, Spiering W, Algra A, Visseren FLJ, (2008) Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease. Journal of internal medicine 264: 351-360.
7. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England journal of medicine 329: 977-986.
8. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes research and clinical practice 28: 103-117.
9. Haller H, Ito S, Izzo JL, Januszewicz A, Katayama S, et al. (2011) Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. The New England journal of medicine 364: 907-917.
10. Ninomiya T, Perkovic V, De Galan BE, Zoungas S, Pillai A, et al. (2009) Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. Journal of the American Society of Nephrology?: JASN 20: 1813-1821.
11. Yokoyama H, Oishi M, Kawai K, Sone H, (2008) Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16. Diabetic medicine: a journal of the British Diabetic Association 25: 1426-1432.
12. Sarnak MJ, Levey AS, (2003) Schoolwerth AC, Coresh J, Culleton B, et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169.
13. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
14. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed) 315: 629-634.
15. Florkowski CM, Scott RS, Coope PA, Moir CL, (2001) Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study. Diabetes research and clinical practice 53: 113-120.
16. Tong PCY, Kong AP, So WY, Yang X, Ng MCY, et al. (2007) Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus. Diabetic medicine?: a journal of the British Diabetic Association 24: 741-746.
17. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, et al. (2010) Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes care 33: 1536-1543.
18. O'Hare AM, Hailpern SM, Pavkov ME, Rios-Burrows N, Gupta I, et al. (2010) Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Archives of internal medicine 170: 930-936.
19. So WY, Kong APS, Ma RCW, Ozaki R, Szeto CC, et al. (2006) Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes care 29: 2046-2052.
20. De Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, et al. (2009) Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes care 32: 1833-1838.
21. Jager A, Kostense PJ, Ruhé HG, Heine RJ, Nijpels G, et al. (1999) Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arteriosclerosis, thrombosis, and vascular biology 19: 617-624.
22. Grauslund J, Jørgensen TMM, Nybo M, Green A, Rasmussen LM, et al. (2010) Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetes. Journal of diabetes and its complications 24: 223-228.
23. Groop P, Thomas MC, Moran JL, Wadèn J, Thorn LM, et al. (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58: 1651-1658.
24. Luk AOY, So W-Y, Ma RCW, Kong APS, Ozaki R, et al. (2008) Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes care 31: 2357-2361.
25. Bruno G, Merletti F, Bargero G, Novelli G, Melis D, et al. (2007) Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia 50: 941-948.
26. Roy M, Rendas-Baum R, Skurnick J, (2006) Mortality in African-Americans with Type 1 diabetes: The New Jersey 725. Diabetic medicine: a journal of the British Diabetic Association 23: 698-706.
27. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, (2006) Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55: 1832-1839.
28. Xu J, Lee ET, Best LG, Begum M, Knowler WC, et al. (2005) Association of albuminuria with all-cause and cardiovascular disease mortality in diabetes: the Strong Heart Study. The British Journal of Diabetes & Vascular Disease 5: 334-340.
29. Yuyun MF, Dinneen SF, Edwards OM, Wood E, Wareham NJ, (2003) Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabetic medicine?: a journal of the British Diabetic Association 20: 277-282.
30. Bruno G, Biggeri A, Merletti F, Bargero G, Ferrero S, et al. (2003) Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study. Diabetes care 26: 2353-2358.
31. Jude EB, Anderson SG, Cruickshank JK, Srivatsa A, Tentolouris N, et al. (2002) Natural history and prognostic factors of diabetic nephropathy in type 2 diabetes. QJM: monthly journal of the Association of Physicians 95: 371-377.
32. Ostgren CJ, Lindblad U, Melander A, Råstam L, (2002) Survival in patients with type 2 diabetes in a Swedish community: skaraborg hypertension and diabetes project. Diabetes care 25: 1297-1302.
33. Stehouwer CDA, Gall M, Twisk JWR, Knudsen E, Emeis JJ, et al. (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51: 1157-1165.
34. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, et al. (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA: the journal of the American Medical Association 286: 421-426.
35. De Grauw WJ, Van de Lisdonk EH, Van Gerwen WH, Verstappen M, Van den Hoogen HJ, et al. (2001) Microalbuminuria in patients with Type 2 diabetes mellitus from general practice: course and predictive value. Diabetic medicine?: a journal of the British Diabetic Association 18: 139-143.
36. Casiglia E, Zanette G, Mazza a, Donadon V, Donada C, et al. (2000) Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. European journal of epidemiology 16: 677-684.
37. Valmadrid CT, Klein R, Moss SE, Klein BE, (2000) The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Archives of internal medicine 160: 1093-1100.
38. Hänninen J, Takala J, Keinänen-Kiukaanniemi S, (1999) Albuminuria and other risk factors for mortality in patients with non-insulin-dependent diabetes mellitus aged under 65 years: a population-based prospective 5-year study. Diabetes research and clinical practice 43: 121-126.
39. Mattock MB, Barnes DJ, Viberti G, Keen H, Burt D, et al. (1998) Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes 47: 1786-1792.
40. Beilin J, Stanton KG, McCann VJ, Knuiman MW, Divitini ML, (1996) Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality. Australian and New Zealand journal of medicine 26: 519-525.
41. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH, (1996) Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (Clinical research ed) 313: 779-784.
42. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH, (1995) Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 44: 1303-1309.
43. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, et al. (1993) A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes care 16: 996-1003.
44. Inventory BD, Index CD, (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American journal of kidney diseases: the official journal of the National Kidney Foundation 39: S1-266.
45. Levey AS, De Jong PE, Coresh J, Nahas M El, Astor BC, et al. (2010) The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney international 80: 17-28.
46. Gross JL, De Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, et al. (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes care 28: 164-176.
47. Dinneen SF, Gerstein HC, (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Archives of internal medicine 157: 1413-1418.
48. Van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, et al. (2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney international 79: 1341-1352.
49. Gansevoort RT, Matsushita K, Van der Velde M, Astor BC, Woodward M, et al. (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations. A collaborative meta-analysis of general and high-risk population cohorts. Kidney International 80: 1-12.
50. Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, et al. (2005) Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. Journal of the American Society of Nephrology?: JASN 16: 3027-3037.
51. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. The New England journal of medicine 329: 1456-1462.
52. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, et al. (2009) Current issues in measurement and reporting of urinary albumin excretion. Clinical chemistry 55: 24-38.
53. Sviridov D, Meilinger B, Drake SK, Hoehn GT, Hortin GL, (2006) Coelution of other proteins with albumin during size-exclusion HPLC: Implications for analysis of urinary albumin. Clinical chemistry 52: 389-397.
54. Brinkman JW, Bakker SJL, Gansevoort RT, Hillege HL, Kema IP, et al. (2004) Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney international Supplement: S69-75.
55. Witte EC, Lambers Heerspink HJ, De Zeeuw D, Bakker SJL, De Jong PE, et al. (2009) First morning voids are more reliable than spot urine samples to assess microalbuminuria. Journal of the American Society of Nephrology: JASN 20: 436-443.
56. Diabetes VII, In C, (2011) Standards of medical care in diabetes-2011. Diabetes care 34Suppl 1: S11-61.
57. KDOQI Clinical Practice Guidelines, Clinical Practice Recommendations for Diabetes, Chronic Kidney Disease, (2007) American journal of kidney diseases?: the official journal of the National Kidney Foundation. 49: S12-154.
58. Levey AS, Eckardt K-U, Tsukamoto Y, Levin A, Coresh J, et al. (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney international 67: 2089-2100.
59. Fox CS, Matsushita K, Woodward M, Bilo HJG, Chalmers J, et al. (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380: 1662-1673.